Vireo Growth (VREOF) Tax Rate (2020 - 2026)
Vireo Growth (VREOF) reported Tax Rate of 435.71% for Q1 2026, down 40030.0% on a YoY basis from N/an in Q1 2025, and down 141.49% sequentially from 180.43% in Q4 2025.
Vireo Growth (VREOF) Tax Rate (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Tax Rate data on file, last reported at 435.71% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 40030.0% year-over-year to 435.71%; the trailing twelve-month figure through Mar 2026 stood at 148.26% (down 10141.0% YoY), and the FY2025 full-year result was 104.25%, down 3848.0% from the prior year.
- Tax Rate declined to 435.71% in Q1 2026, from 180.43% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 36.77% in Q4 2023 to a low of 435.71% in Q1 2026.
- A 5-year average of 93.65% and a median of 38.24% in 2024 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate soared 14448 bps in 2025 and plunged 40030 bps in 2026, its largest moves.
- Tracing VREOF's Tax Rate over 5 years: stood at 26.65% in 2022, then jumped by 238 bps to 36.77% in 2023, then slumped by 204 bps to 38.24% in 2024, then plunged by 372 bps to 180.43% in 2025, then slumped by 141 bps to 435.71% in 2026.
- Business Quant data shows VREOF's Tax Rate at 435.71% in Q1 2026, 180.43% in Q4 2025, and 103.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -435.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -435.71% |
| Mar 31, 2026 | -435.71% |
| Mar 31, 2026 | -435.71% |
| Dec 31, 2025 | -180.43% |
| Dec 31, 2025 | -180.43% |
| Dec 31, 2025 | -180.43% |
| Sep 30, 2025 | -103.05% |
| Sep 30, 2025 | -103.05% |
| Sep 30, 2025 | -103.05% |
| Jun 30, 2025 | -48.15% |
| Jun 30, 2025 | -48.15% |
| Jun 30, 2025 | -48.15% |
| Mar 31, 2025 | -35.42% |
| Mar 31, 2025 | -35.42% |
| Mar 31, 2025 | -35.42% |
| Dec 31, 2024 | -38.24% |
| Dec 31, 2024 | -38.24% |
| Dec 31, 2024 | -38.24% |
| Sep 30, 2024 | -93.85% |
| Sep 30, 2024 | -93.85% |